Search OPRX
OptimizeRx Corp
Nasdaq · CIK 1448431
Last close8.57
Daily change+0.18 (2.15%)
10 Years gain+159.70%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
OPRX · STANDARD
SIC 7389 · Services-Business Services, NEC · Fiscal year end 1231
Fundamental
76.8Momentum
100.0Acceleration
100.0Confidence
91.0Annual Revenue16
Quarterly Revenue54
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth22.8 / 25
Quality20.9 / 25
Capital Efficiency9.0 / 20
Balance Sheet12.7 / 15
Shareholder Economics6.5 / 10
Forward Indicators5.0 / 5
Signals
Gross margin expansionGross margin improved by 7.8114 percentage points.
Operating leverageOperating margin improved by 29.606 percentage points.
ROIC expansionROIC improved by 17.7741 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM16.97%OK
Revenue CAGR 3Y374.39%OK
Gross Margin69.84%OK
Operating Margin5.82%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC2.61%OK
Incremental Operating Margin 3Y33.7%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y1.7%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $109.43M | $73.60M | $11.69M | $18.72M | $18.66M | 67.25% | 10.69% | 17.05% | 6.42% | 19M |
| 2025 FY Dec 31, 2024 | $92.13M | $59.38M | -$13.71M | $4.89M | $4.78M | 64.45% | -14.88% | 5.19% | -7.5% | 18.29M |
| 2024 FY Dec 31, 2023 | $71.52M | $42.90M | -$26.40M | -$7.24M | -$7.33M | 59.98% | -36.91% | -10.24% | -20.55% | 17.12M |
| 2023 FY Dec 31, 2022 | n/a | $38.97M | -$12.29M | $10.65M | $10.57M | n/a | n/a | n/a | n/a | 17.78M |
| 2022 FY Dec 31, 2022 | $1.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $95.61M | sum latest 4 fiscal quarters Revenue | OK | 0001448431-26-000016, 0001448431-25-000020 |
| Revenue Growth TTM | 16.97% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001448431-26-000016, 0001448431-25-000020 |
| Revenue CAGR 3Y | 374.39% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001448431-26-000005 |
| Revenue CAGR 5Y | 20.37% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001448431-26-000005 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001448431-26-000005 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001448431-26-000016, 0001448431-25-000020 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 69.84% | Gross Profit / Revenue | OK | 0001448431-26-000016, 0001448431-25-000020 |
| Operating Margin | 5.82% | Operating Income / Revenue | OK | 0001448431-26-000016, 0001448431-25-000020 |
| ROIC | 2.61% | NOPAT / Average Invested Capital | OK | 0001448431-26-000016, 0001448431-25-000020 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001448431-26-000016 |
| Current Ratio | 5.58x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 1.22x | (Cash + Short-term Investments) / Total Debt | OK | 0001448431-26-000016 |
| Revenue per Diluted Share | $5.09 | Revenue / Diluted Shares | OK | 0001448431-26-000016, 0001448431-25-000020 |